Lungpacer is conducting research as an FDA Breakthrough Device.

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat

0
Scientific
Presentations
0
Peer Reviewed
Publications
0
Patient
Studied
img-top-page-1

Lungpacer is studying

Lungpacer Strengthens
the Diaphragm and Improves
Lung Function.

200 %
Stronger
Diaphragm (MIP)

3,4

100 %
Improved
Lung Function (MIP)

3,4

Data, results and trends from three years of clinical studies:

%
Increase in
Ventilation Weaning
%
Greater
Survival
Days
Less on a Ventilator

Lungpacer mitigates lung injury

Lungpacer mitigates brain injury

Get in touch.

Contact us to schedule a discussion, learn more about our clinical trial, or to get more information.